Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV vs Oral Dexamethasone for PONV in Pediatric Tonsillectomy
NCT04563494Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Oct 2020
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Post-operative Nausea at 4 hours and Post-operative Vomiting at 4 hours. Started Oct 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on NCT04563494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04563494.